India's Richest People 2026 edition · 1 director · Source: Hurun India
- #428 Chigurupati Krishna Prasad ₹8,700 Cr
Revenue · FY 2025
₹62.88 Cr
▲ 47896% YoY
Net profit · FY 2025
₹5.52 Cr
Net margin 8.8%
EBITDA · FY 2025
₹10.55 Cr
EBITDA margin 16.8%
Authorised capital
₹1,000 Cr
Registered with MCA
Paid-up capital
₹925 Cr
Issued & subscribed
Open charges
₹400 Cr
Satisfied ₹400 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
23
Provident fund records
About Granules Life Sciences Private Limited
Data last updated:
Granules Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Granules India Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 2020 and has been in existence for over 6 years.
Its director Chigurupati Krishna Prasad is #428 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC146042. Its GSTIN is 36AAICG7068D1ZH (Telangana).
The company has an authorised share capital of ₹1,000 Cr and a paid-up capital of ₹925 Cr. It is led by directors including Rajiv Pritidas Kakodkar and Chigurupati Krishna Prasad.
Its last annual general meeting (AGM) was held on 05 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.88 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.52 Cr (net margin 8.8%) and EBITDA of ₹10.55 Cr (EBITDA margin 16.8%). Revenue has grown at a compounded annual rate (CAGR) of 670% over three years.
The company has about 23 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹400 Cr and satisfied charges of ₹400 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 1 deal on record (1 rights issue); the latest was in May 2021. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Chandra Life Sciences Private Limited with revenue of ₹63.01 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website granulesindia.com.
Company details
CIN U24290TG2020PTC146042
Registration Number 146042
Incorporation Date 18 November 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 August 2026
Date of Balance Sheet 31 March 2026
Parent Company Granules India Limited
Compliance Status Active Compliant
Key People
Rajiv Pritidas Kakodkar Director Chigurupati Krishna Prasad Director Harsha Chigurupati Director Recognitions & Rankings of Granules Life Sciences
Contact details
Granules Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is granulesindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address15th Floor Granules Tower, Botanical Garden Road, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Granules Life Sciences Private Limited, buy the company report.
Comprehensive company report
Granules Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Granules Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Granules Life Sciences Private Limited, buy the company report.
Financials of Granules Life Sciences Private Limited
FY 2026 filings availableGranules Life Sciences Private Limited reported revenue of ₹62.88 Cr (up 47896% YoY) for FY 2025.
Revenue · FY 2025
₹62.88 Cr ▲ 47896%
Net profit · FY 2025
₹5.52 Cr margin 8.8%
EBITDA · FY 2025
₹10.55 Cr margin 16.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 670%
EBITDA CAGR growth
3 years · compounded
▲ 454%
Revenue has grown at a compounded annual rate (CAGR) of 670% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.8% | ||||
| Net Profit Margin | 8.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Granules Life Sciences Private Limited, buy the company report.
Board of directors of Granules Life Sciences Private Limited
Granules Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Pritidas Kakodkar Also directs: Granules India Limited, Ascelis Peptides Private Limited | Director | 30 Mar 2024 | 2 Years 6 Months | Current |
| Chigurupati Krishna Prasad | Director | 18 Nov 2020 | 5 Years 11 Months | Current |
| Harsha Chigurupati | Director | 05 Aug 2026 | 0 Years 2 Months | Current |
| Umadevi Chigurupati Also directs: Krsma Hospitality LLP, Granules India Limited, Krsma Vineyards Private Limited and 5 more | Director | 30 Mar 2024 | 2 Years 6 Months | Current |
Peer comparison
Granules Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chandra Life Sciences Private Limited | ₹63.01 Cr (FY 2024) | 4.0% | Hyderabad, Telangana, India | |||
| Vedant Dyestuffs Intermediates Private Limited | ₹62.97 Cr (FY 2025) | 104.0% | Mumbai, Maharashtra, India | |||
| Lakshmisaraswathi Chemicals and Organics Private Limited | ₹62.96 Cr (FY 2025) | 14.0% | Medak, Telangana, India | |||
| PR Pharma Engineers Private Limited | ₹62.91 Cr (FY 2025) | -14.0% | Hyderabad, Telangana, India | |||
| Thinq Pharma-Cro Limited | ₹62.89 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Granules Life Sciences Private Limitedthis company | ₹62.88 Cr (FY 2025) | ₹5.52 Cr | 8.8% | 47896.0% | Hyderabad, Telangana, India | |
| Preet Remedies Limited | ₹62.83 Cr (FY 2025) | 18.0% | Chandigarh, India | |||
| SKC Chemie Private Limited | ₹62.83 Cr (FY 2025) | 13.0% | Navi Mumbai, Maharashtra, India | |||
| Dhandapani Cements Private Limited | ₹62.78 Cr (FY 2024) | -27.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Balaji Sourcings Private Limited | ₹62.7 Cr (FY 2019) | 25.0% | Solapur, Maharashtra, India | |||
| Dhanuka Udyog Private Limited | ₹62.67 Cr (FY 2024) | -1.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Granules Life Sciences Private Limited, buy the company report.
Auditor
Granules Life Sciences Private Limited is audited by S.R. Batliboi & Associates LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R. Batliboi & Associates LLP | FY 2024 | 101049W/E300004 |
Shareholding
The shareholding of Granules Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Granules Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹400 Cr
Satisfied charges
₹400 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Feb 2024 | 100880384 | Sbicap Trustee Company Limited | ₹400 Cr | Satisfied |
To see the full charge records of Granules Life Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Granules Life Sciences Private Limited has 1 deal on record (1 rights issue); the latest was in May 2021.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2021 | Rights issue | ₹25 Cr | Investors: Granules India Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Granules Life Sciences Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed against the company by Southern Power Distribution Company of Telangana Limited, | Pending |
To see the full case history of Granules Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Granules Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Granules Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICG7068D1ZH | Telangana | Active | 01 Mar 2022 |
To see the full GST registrations and return filing status of Granules Life Sciences Private Limited, buy the company report.
Recent activity
Granules Life Sciences Private Limited has 5 board changes on record since 2020: 4 appointments and 1 cessation. The latest: Harsha Chigurupati was appointed as Director on 05 Aug 2026.
AGM
Granules Life Sciences Private Limited last Annual general meeting of members was held on 05 Aug 2026 as per latest MCA records.
Appointed
Harsha Chigurupati was appointed as Director.
Charges
A charge registered on 20 Feb 2024 via Charge ID 100880384 with Sbicap Trustee Company Limited was fully satisfied on 24 Apr 2026.
Filing
Granules Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Ceased
Priyanka Chigurupati ceased to be Director.
Appointed
Rajiv Pritidas Kakodkar was appointed as Director.
Appointed
Umadevi Chigurupati was appointed as Director.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 400.00 Cr with Charge ID 100880384 was registered on 20 Feb 2024.
Appointed
Chigurupati Krishna Prasad was appointed as Director.
Incorporation
18 Nov 2020
Granules Life Sciences Private Limited was registered on 18 Nov 2020 with Roc Hyderabad & aged 5 years 11 months as per MCA records.
News
Frequently asked questions
Granules Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 2020 (6+ years old) and is registered under CIN U24290TG2020PTC146042.
Granules Life Sciences has 4 current directors:
- Rajiv Pritidas Kakodkar - Director
- Chigurupati Krishna Prasad - Director
- Harsha Chigurupati - Director
- Umadevi Chigurupati - Director
The latest financial statements of Granules Life Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 05 August 2026. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Granules Life Sciences is 36AAICG7068D1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Granules Life Sciences is U24290TG2020PTC146042. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Granules Life Sciences has 1 court case on record: 1 filed against it. 1 is pending.
Granules Life Sciences was incorporated on 18 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Granules Life Sciences has 1 deal on record (1 rights issue); the latest was in May 2021.
The peers of Granules Life Sciences by revenue are Chandra Life Sciences Private Limited, Vedant Dyestuffs Intermediates Private Limited, Lakshmisaraswathi Chemicals and Organics Private Limited, PR Pharma Engineers Private Limited, Thinq Pharma-Cro Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harsha Chigurupati was appointed as Director on 05 Aug 2026. Priyanka Chigurupati ceased to be Director on 30 Mar 2024. Rajiv Pritidas Kakodkar was appointed as Director on 30 Mar 2024. Granules Life Sciences has 5 board changes on record in total.
Granules Life Sciences can be reached through the website granulesindia.com. Its registered office is in Hyderabad, Telangana, India.